Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
Electromantles Engineered for Safety
Tuesday, June 30, 2015
Bibby Scientific’s Electromantles® from Electrothermal are engineered for safe and reliable heating of lab chemicals.
Merck Millipore Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
Tuesday, June 16, 2015
Services accelerate time to the clinic by delivering high quality, high expressing cell lines.
Mylan Launches First Bioequivalent Alternative to Seretide® Evohaler®
Friday, June 12, 2015
Mylan becomes the first company to market a generic version of the UK's number one prescribed long-acting beta2-agonist + inhaled corticosteroid pressurized metered-dose inhaler asthma therapy.
Chemcap Clearview Cabinets are Easy to Assemble
Thursday, May 14, 2015
Bigneat knows that not everyone takes naturally to the idea of ‘do-it-yourself’. However, the easy-to-follow instructions and detailed diagrams in their new ‘Shortform User Manual’ show how easy it is to self-assemble your own ductless fume cabinet, whether you’re a flat-pack furniture novice or ‘build-your-own’ virtuoso.
Catalent Launches ADVASEPT™ Lock Delivery Technology
Friday, April 24, 2015
Company announces the expansion of its advanced, aseptic, glass-free injectable platform.
Rentschler Expands European Manufacturing Capabilities
Thursday, April 16, 2015
Companies celebrate handover of 1000th ÄKTAprocess.
A New Test to Simultaneously Detect 22 Respiratory Pathogens
Tuesday, April 07, 2015
Luminex® Corporation launches the NxTAG™ Respiratory Pathogen Panel (RUO) - A closed-tube, flexibly scalable solution for respiratory testing.
Expert System Optimizes Discovery of Drugs
Tuesday, April 07, 2015
Pharmaceutical companies use the expert system IMPACT-F to forecast drug-uptake in humans.
High ThroughputPARP in vivo Pharmacodynamic Assay
Monday, February 23, 2015
AMSBIO has introduced a unique High Throughput PARP in vivo Pharmacodynamic Assay that can be used to monitor the efficacy of poly-ADP-ribose polymerase (PARP) inhibitors on PAR formation in vivo; and to measure drug action on PARP in both in vivo and in vitro settings.
Showing Results 21 - 30 of 326
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
PREVAIL Treatment Trial for Men with Persistent Ebola Viral RNA
The six-month study will enroll 60 to 120 EVD survivors.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to
modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,300+ scientific and medical posters
4,900+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!